14-day Premium Trial Subscription Try For FreeGet Free
$0.628
+0.0760 (+13.76%)
At Close: Dec 01, 2023
Chart & Forecast Earnings Insider Trading Signals Historical Prices Predictions News Profile
Date Action Amount Person Type
Nov 01, 2023 Sell 21 841 Wettig Thane Common Stock
Sep 22, 2023 Sell 819 Wettig Thane Common Stock
Sep 06, 2023 Sell 711 Graham Juan Common Stock
Sep 07, 2023 Sell 1 096 Graham Juan Common Stock
Sep 06, 2023 Sell 1 680 Wettig Thane Common Stock
Sep 06, 2023 Sell 1 860 Eisner Mark Common Stock
Sep 06, 2023 Sell 3 308 Chung Christine Common Stock
Sep 01, 2023 Sell 1 085 Eisner Mark Common Stock
Sep 01, 2023 Sell 2 000 Henderson Jeffrey William Common Stock
Aug 30, 2023 Buy 220 000 Graham Juan Stock Option (Right to Buy)
Aug 30, 2023 Buy 120 000 Graham Juan Common Stock
Aug 30, 2023 Buy 120 000 Chung Christine Common Stock
Aug 30, 2023 Buy 220 000 Chung Christine Stock Option (Right to Buy)
Aug 10, 2023 Buy 10 000 Schoeneck James A Stock Option (Right to Buy)
Aug 07, 2023 Buy 200 000 Wettig Thane Common Stock
Aug 07, 2023 Buy 300 000 Wettig Thane Stock Option (Right to Buy)
Aug 04, 2023 Sell 2 000 Henderson Jeffrey William Common Stock
Jul 11, 2023 Sell 2 000 Henderson Jeffrey William Common Stock
Jul 07, 2023 Sell 1 880 Conterno Enrique A Common Stock
Jun 23, 2023 Sell 791 Wettig Thane Common Stock
Jun 07, 2023 Sell 472 Wettig Thane Common Stock
Jun 07, 2023 Sell 1 286 Wettig Thane Common Stock
Jun 13, 2023 Sell 6 250 Chung Christine Common Stock
Jun 14, 2023 Sell 5 250 Chung Christine Common Stock
Jun 14, 2023 Sell 1 000 Chung Christine Common Stock
Jun 07, 2023 Buy 8 289 Cravatt Benjamin Common Stock
Jun 09, 2023 Sell 1 766 Cravatt Benjamin Common Stock
Jun 09, 2023 Sell 2 178 Cravatt Benjamin Common Stock
Jun 07, 2023 Buy 12 666 Cravatt Benjamin Stock Option (Right to Buy)
Jun 07, 2023 Buy 8 289 Brennan Aoife Common Stock
Jun 09, 2023 Sell 1 994 Brennan Aoife Common Stock
Jun 09, 2023 Sell 2 739 Brennan Aoife Common Stock
Jun 07, 2023 Buy 12 666 Brennan Aoife Stock Option (Right to Buy)
Jun 07, 2023 Buy 8 289 Blaug Suzanne Common Stock
Jun 09, 2023 Sell 3 351 Blaug Suzanne Common Stock
Jun 09, 2023 Sell 5 169 Blaug Suzanne Common Stock
Jun 07, 2023 Buy 12 666 Blaug Suzanne Stock Option (Right to Buy)
Jun 07, 2023 Buy 8 289 Ho Maykin Common Stock
Jun 08, 2023 Sell 2 295 Ho Maykin Common Stock
Jun 08, 2023 Sell 6 225 Ho Maykin Common Stock
Jun 07, 2023 Buy 12 666 Ho Maykin Stock Option (Right to Buy)
Jun 07, 2023 Buy 8 289 Lema Gerald Common Stock
Jun 07, 2023 Buy 12 666 Lema Gerald Stock Option (Right to Buy)
Jun 07, 2023 Buy 8 289 Edwards Jeffrey L Common Stock
Jun 09, 2023 Sell 3 265 Edwards Jeffrey L Common Stock
Jun 09, 2023 Sell 4 624 Edwards Jeffrey L Common Stock
Jun 07, 2023 Buy 12 666 Edwards Jeffrey L Stock Option (Right to Buy)
Jun 07, 2023 Buy 8 289 Henderson Jeffrey William Common Stock
Jun 08, 2023 Sell 2 006 Henderson Jeffrey William Common Stock
Jun 08, 2023 Sell 4 994 Henderson Jeffrey William Common Stock
Jun 07, 2023 Buy 12 666 Henderson Jeffrey William Stock Option (Right to Buy)
Jun 07, 2023 Sell 7 100 Schoeneck James A Common Stock
Jun 07, 2023 Buy 8 289 Schoeneck James A Common Stock
Jun 07, 2023 Buy 12 666 Schoeneck James A Stock Option (Right to Buy)
Jun 07, 2023 Sell 472 Wettig Thane Common Stock
Jun 07, 2023 Sell 1 286 Wettig Thane Common Stock
Jun 07, 2023 Sell 1 050 Graham Juan Common Stock
Jun 07, 2023 Sell 735 Graham Juan Common Stock
Jun 07, 2023 Sell 1 362 Chung Christine Common Stock
Jun 07, 2023 Sell 739 Chung Christine Common Stock
Jun 07, 2023 Sell 1 532 Chung Christine Common Stock
Jun 07, 2023 Sell 2 042 Eisner Mark Common Stock
Jun 07, 2023 Sell 2 791 Conterno Enrique A Common Stock
Jun 07, 2023 Sell 6 106 Conterno Enrique A Common Stock
Jun 02, 2023 Sell 1 090 Eisner Mark Common Stock
Apr 10, 2023 Sell 1 869 Conterno Enrique A Common Stock
Apr 04, 2023 Sell 9 182 Eisner Mark Common Stock
Apr 04, 2023 Sell 6 590 Chung Christine Common Stock
Mar 20, 2023 Sell 2 343 Wettig Thane Common Stock
Mar 20, 2023 Buy 1 000 Wettig Thane Common Stock
Mar 23, 2023 Sell 905 Wettig Thane Common Stock
Mar 10, 2023 Sell 19 489 Conterno Enrique A Common Stock
Mar 08, 2023 Buy 9 338 Chung Christine Common Stock
Mar 10, 2023 Sell 4 692 Chung Christine Common Stock
Mar 10, 2023 Sell 2 914 Chung Christine Common Stock
Mar 08, 2023 Buy 5 799 Chung Christine Common Stock
Mar 08, 2023 Sell 8 354 Chung Christine Common Stock
Mar 08, 2023 Buy 37 229 Conterno Enrique A Common Stock
Mar 10, 2023 Sell 12 103 Conterno Enrique A Common Stock
Mar 10, 2023 Sell 19 486 Conterno Enrique A Common Stock
Mar 08, 2023 Buy 23 120 Conterno Enrique A Common Stock
Mar 08, 2023 Sell 24 672 Conterno Enrique A Common Stock
Mar 08, 2023 Buy 12 451 Eisner Mark Common Stock
Mar 10, 2023 Sell 3 885 Eisner Mark Common Stock
Mar 10, 2023 Sell 6 255 Eisner Mark Common Stock
Mar 08, 2023 Buy 7 732 Eisner Mark Common Stock
Mar 08, 2023 Sell 7 363 Eisner Mark Common Stock
Mar 08, 2023 Buy 4 668 Graham Juan Common Stock
Mar 10, 2023 Sell 1 112 Graham Juan Common Stock
Mar 10, 2023 Sell 1 456 Graham Juan Common Stock
Mar 08, 2023 Buy 2 899 Graham Juan Common Stock
Mar 10, 2023 Sell 2 344 Graham Juan Common Stock
Mar 08, 2023 Sell 2 749 Graham Juan Common Stock
Mar 08, 2023 Buy 9 338 Wettig Thane Common Stock
Mar 10, 2023 Sell 2 938 Wettig Thane Common Stock
Mar 10, 2023 Sell 4 731 Wettig Thane Common Stock
Mar 08, 2023 Buy 5 799 Wettig Thane COmmon Stock
Mar 08, 2023 Sell 6 265 Wettig Thane Common Stock
Mar 02, 2023 Sell 1 187 Eisner Mark Common Stock
Feb 21, 2023 Buy 25 000 Wettig Thane Common Stock
INSIDER POWER
69.243
Last 100 transactions
Buy: 1 502 013 | Sell: 275 124 (Shares)

Based on the 100 latest insides trades, we have calculated the insider power to be positive at a ratio of 69.243.

In total, the insiders bought 1 502 013 and sold 275 124 FGEN shares in the last 100 trades.

Click to get the best stock tips daily for free!

About FibroGen

FibroGen FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. The company is developing Roxadustat, an oral small molecule inhibitor of hypoxia inducible factor prolyl hydroxylases, which has completed Phase III clinical development for the treatment of anemia in chronic kidney disease in the United States, Europe, China, and Japan; and in Phase II/III development in China ... FGEN Profile

Golden Star

Ticker Date Change Price
PAGP Nov 29 2.64% $15.92
AMRC Nov 29 11.93% $28.34
ESS Nov 29 3.97% $212.23
CP Nov 29 4.92% $71.32
AN Nov 29 4.47% $134.13
AZN Nov 29 1.04% $64.12
CGNX Nov 27 4.52% $36.74
WEC Nov 24 4.05% $81.66
PEAK Nov 24 9.31% $16.65
NAVI Nov 24 5.11% $16.84
Unlock

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT